Latest Insider Transactions at Drugs Made In America Acquisition Corp. (DMAA)
This section provides a real-time view of insider transactions for Drugs Made In America Acquisition Corp. (DMAA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Drugs Made In America Acquisition Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Drugs Made In America Acquisition Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2025
|
Lynn Stockwell CEO and Executive COB |
SELL
Open market or private sale
|
Indirect |
5,698,363
-57.81%
|
-
|
|
Jan 29
2025
|
Lynn Stockwell CEO and Executive COB |
SELL
Other acquisition or disposition
|
Indirect |
400,000
-3.9%
|
-
|
|
Jan 29
2025
|
Lynn Stockwell CEO and Executive COB |
BUY
Open market or private purchase
|
Indirect |
400,000
+97.5%
|
-
|
|
Jan 29
2025
|
Drugs Made In America Acquisition LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,698,363
-57.81%
|
-
|
|
Jan 29
2025
|
Drugs Made In America Acquisition LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
400,000
-3.9%
|
-
|
|
Jan 29
2025
|
Drugs Made In America Acquisition LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
400,000
+3.75%
|
-
|
|
Jan 29
2025
|
Sridhar G. Prasad Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Jan 29
2025
|
Myron W. Shulgan Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Jan 29
2025
|
Glenn C. Worman CFO |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Jan 29
2025
|
Catherine Do Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|